2024
Ankle Impingement
Hartman H, Joo P, Gianakos A. Ankle Impingement. 2024, 323-335. DOI: 10.1007/978-981-97-4202-8_19.Peer-Reviewed Original ResearchPlatelet rich plasma therapy versus other modalities for treatment of plantar fasciitis: A systematic review and meta-analysis
Herber A, Covarrubias O, Daher M, Tung W, Gianakos A. Platelet rich plasma therapy versus other modalities for treatment of plantar fasciitis: A systematic review and meta-analysis. Foot And Ankle Surgery 2024, 30: 285-293. PMID: 38395675, DOI: 10.1016/j.fas.2024.02.004.Peer-Reviewed Original ResearchFoot Function IndexPlantar fascia thicknessExtracorporeal shock wave therapyPlantar fasciitisRandomized Controlled TrialsVisual analog scaleAmerican Orthopaedic Foot and Ankle Society (AOFAS) ankle-hindfoot scorePlatelet-rich plasmaCause of heel painOutcome measuresFoot Function Index scoreTreatment of plantar fasciitisCorticosteroid injectionDextrose prolotherapyMean differenceAnkle-hindfoot scoreMeta-analysisPain scoresShock wave therapyFoot functionFascia thicknessHeel painMusculoskeletal conditionsTrigger pointsManagement of PFCorticosteroid Injections Administered Within 4 Weeks Prior to Hip Arthroscopy Are Associated With Higher Rates of Postoperative Infection
Surucu S, Halperin S, Monahan P, Gillinov S, Lee M, Grauer J, Jimenez A. Corticosteroid Injections Administered Within 4 Weeks Prior to Hip Arthroscopy Are Associated With Higher Rates of Postoperative Infection. Arthroscopy The Journal Of Arthroscopic And Related Surgery 2024, 40: 2381-2385.e1. PMID: 38311263, DOI: 10.1016/j.arthro.2024.01.016.Peer-Reviewed Original ResearchSurgical-site infectionIntra-articular corticosteroid injectionCorticosteroid injectionPostoperative infectionHip arthroscopyRate of surgical-site infectionPostoperative surgical-site infectionIncidence of postoperative infectionPresence of diabetes mellitusRate of postoperative infectionSurgical-site infection ratesRisk of postoperative infectionRate of wound dehiscenceHip corticosteroid injectionsMultivariate logistic regression analysisHip arthroscopy casesRetrospective comparative studyPreoperative corticosteroid injectionsHip arthroscopy surgeryAdministrative claims databaseLogistic regression analysisInfection rateCurrent Procedural TerminologyElixhauser Comorbidity IndexWound dehiscence
2023
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co‐Expression Patterns: A Double‐Blind, Randomized, Placebo‐Controlled, Phase 2 Trial
Merrill J, Guthridge J, Smith M, June J, Koumpouras F, Machua W, Askanase A, Khosroshahi A, Sheikh S, Rathi G, Burington B, Foster P, Matijevic M, Arora S, Wang X, Gao M, Wax S, James J, Zack D. Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co‐Expression Patterns: A Double‐Blind, Randomized, Placebo‐Controlled, Phase 2 Trial. Arthritis & Rheumatology 2023, 75: 2185-2194. PMID: 37459248, DOI: 10.1002/art.42652.Peer-Reviewed Original ResearchConceptsSystemic lupus erythematosusLoss of improvementPrimary endpointLupus erythematosusWeek 32B cellsEfficacy-evaluable populationImproved disease activityPhase 2 trialProportion of patientsTreatment-related toxicityTreatment of patientsPlacebo-ControlledCorticosteroid injectionDisease activityInfusion reactionsTrough concentrationsPatient subsetsPlasma cellsPatientsSecondary analysisMonoclonal antibodiesStatistical significanceEndpointPlaceboRisk of SARS‐CoV‐2 following joint and epidural corticosteroid injections: A retrospective study
Raju R, Holder E, Dundas M, Liang J, Donham R. Risk of SARS‐CoV‐2 following joint and epidural corticosteroid injections: A retrospective study. Pain Practice 2023, 24: 472-482. PMID: 37994676, DOI: 10.1111/papr.13321.Peer-Reviewed Original ResearchPCR positivity ratesCharlson Comorbidity IndexInjection groupPositivity rateCS injectionsControl groupCorticosteroid injectionSevere comorbiditiesPolymerase chain reaction positivitySARS-CoV-2 PCREpidural corticosteroid injectionsRetrospective chart reviewTertiary care centerCohort of patientsSignificant disease burdenCoronavirus disease 2019 (COVID-19) pandemicSignificant higher rateSARS-CoV-2Disease 2019 pandemicMultivariate regression analysisComorbidity indexPatients 18Chart reviewRetrospective studyImmunosuppressive effects
2022
Development and Resolution of Secondary Adrenal Insufficiency after an Intra‐Articular Steroid Injection
Tan J, Majumdar S. Development and Resolution of Secondary Adrenal Insufficiency after an Intra‐Articular Steroid Injection. Case Reports In Endocrinology 2022, 2022: 4798466. PMID: 36588627, PMCID: PMC9800097, DOI: 10.1155/2022/4798466.Peer-Reviewed Original ResearchSecondary adrenal insufficiencyIntra-articular steroid injectionHypothalamic-pituitary axisSteroid injectionAdrenal insufficiencyIntra-articular steroidsIatrogenic Cushing's syndromeNonspecific gastrointestinal symptomsLow morning cortisolCorticosteroid usersSystemic corticosteroidsCorticosteroid injectionGastrointestinal symptomsLocal corticosteroidsNonspecific symptomsCushing's syndromeFurther workupInitial diagnosisAdrenal axisHPA responsivenessInflammatory conditionsTendon sheathMorning cortisolLower riskClinical practiceNo Difference in Complication or Reoperation Rates Between Arthroscopic and Open Debridement for Lateral Epicondylitis: A National Database Study
Moran J, Gillinov SM, Jimenez AE, Schneble CA, Manzi JE, Vaswani R, Mathew JI, Nicholson AD, Kunze KN, Gulotta LV, Altchek DW, Dines JS. No Difference in Complication or Reoperation Rates Between Arthroscopic and Open Debridement for Lateral Epicondylitis: A National Database Study. Arthroscopy The Journal Of Arthroscopic And Related Surgery 2022, 39: 245-252. PMID: 36049587, DOI: 10.1016/j.arthro.2022.08.022.Peer-Reviewed Original ResearchConceptsArthroscopic debridementReoperation rateOpen debridementLateral epicondylitisPlatelet-rich plasma injectionExtensor carpi radialis brevisNational database studyRadial nerve injuryNonoperative treatment modalitiesSurgical site infectionCarpi radialis brevisCommon extensor tendonICD-10 codesCross-sectional studyLogistic regression analysisSignificant differencesOD cohortCorticosteroid injectionNonoperative treatmentPostoperative complicationsSepsis eventsAdverse eventsComplication rateNerve injurySite infection
2021
Pain Management in Painful Psoriasis and Psoriatic Arthropathy: Challenging and Intricately Intertwined Issues Involving Several Systems
Kodumudi V, Rajput K. Pain Management in Painful Psoriasis and Psoriatic Arthropathy: Challenging and Intricately Intertwined Issues Involving Several Systems. Current Pain And Headache Reports 2021, 25: 36. PMID: 33821380, DOI: 10.1007/s11916-021-00952-5.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsPrimary disease burdenPsoriatic arthropathyDisease burdenInflammatory autoimmune conditionMild topical steroidsNon-steroidal medicationsPurpose of ReviewPsoriasisSystemic immunomodulatory agentsOptimal clinical managementTreatment of painVitamin D analogsQuality of lifeRecent FindingsPainCorticosteroid injectionPain controlTopical steroidsPsoriatic diseaseUnderlying diseaseAutoimmune conditionsPain managementAssociated painInterventional optionsImmunomodulatory agentsClinical managementSevere disease
2013
Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?
Losina E, Daigle ME, Suter LG, Hunter DJ, Solomon DH, Walensky RP, Jordan JM, Burbine SA, Paltiel AD, Katz JN. Disease-modifying drugs for knee osteoarthritis: can they be cost-effective? Osteoarthritis And Cartilage 2013, 21: 655-667. PMID: 23380251, PMCID: PMC3670115, DOI: 10.1016/j.joca.2013.01.016.Peer-Reviewed Original ResearchConceptsIncremental cost-effectiveness ratioQuality-adjusted life yearsTotal knee replacementPain reliefMajor toxicityRevision total knee replacementCare sequenceConservative pain managementGuideline-concordant careKnee OA treatmentQuality-adjusted life expectancyOsteoarthritis Policy ModelCost-effectiveness ratioCorticosteroid injectionKnee OAKnee osteoarthritisPain managementOsteoarthritis drugsKnee replacementDMOADsOA treatmentLife yearsProgressionLife expectancyRelief
2007
Trigger finger: etiology, evaluation, and treatment
Makkouk AH, Oetgen ME, Swigart CR, Dodds SD. Trigger finger: etiology, evaluation, and treatment. Current Reviews In Musculoskeletal Medicine 2007, 1: 92-96. PMID: 19468879, PMCID: PMC2684207, DOI: 10.1007/s12178-007-9012-1.Peer-Reviewed Original ResearchTraumatic soft tissue injuriesDuration of symptomsLoss of motionSoft tissue injuriesCorticosteroid injectionDiabetic populationMost patientsSurgical releaseTrigger fingerA1 pulleyAffected fingerTreatment modalitiesSixth decadeTissue injuryPathological processesSubsequent narrowingFingerPainInflammationPatientsSplintingEtiologyInjurySymptomsTumors
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply